TREATMENT OF HYPERKALEMIA WITH INTRAVENOUS SALBUTAMOL

被引：26

作者：

MURDOCH, IA

DOSANJOS, R

HAYCOCK, GB

机构：

[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP, GUYS HOSP,DEPT PAEDIAT NEPHROL,12TH FLOOR, GUYS TOWER, LONDON SE1 9RT, ENGLAND

[2] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP, GUYS HOSP, DEPT PAEDIAT CARDIOL, LONDON SE1 9RT, ENGLAND

来源：

ARCHIVES OF DISEASE IN CHILDHOOD | 1991年 / 66卷 / 04期

关键词：

D O I：

10.1136/adc.66.4.527

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Thirteen children with hyperkalaemia were treated by intravenous infusions of salbutamol, 4-mu-g/kg over 20 minutes. Reductions in the mean (SD) plasma potassium concentrations, of 1.48 (0.5) and 1.64 (0.5) mmol/l were obtained at 40 and 120 minutes, respectively, after completion of the infusions. No side effects were noted.

引用

页码：527 / 528

页数：2

共 6 条

[1]

BLUMBERG A, 1988, AM J MED, V85, P507

[2]

LENS XM, 1989, NEPHROL DIAL TRANSPL, V4, P228

[3] ADRENERGIC MODULATION OF EXTRA-RENAL POTASSIUM DISPOSAL [J].

ROSA, RM ;

SILVA, P ;

YOUNG, JB ;

LANDSBERG, L ;

BROWN, RS ;

ROWE, JW ;

EPSTEIN, FH .

NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (08) :431-434

[4]

SCOTLAND SM, 1983, LANCET, V2, P216

[5] IMPAIRMENT OF BETA2-ADRENOCEPTOR-STIMULATED POTASSIUM UPTAKE IN END-STAGE RENAL-DISEASE [J].

STEMMER, CL ;

PEREZ, GO ;

OSTER, JR .

JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (08) :628-631

[6]

WANG P, 1976, LANCET, V1, P221

← 1 →